MSP Medicines LLP - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
LLPIN AAE-2082 Incorporated 19 June 2015 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Limited Liability Partnership pharma MSME · Medium
Revenue · FY 2023
₹27.9 Cr
Latest filing
Net profit · FY 2023
₹4.89 Cr
Net margin 17.5%
EBITDA · FY 2023
₹10.38 Cr
EBITDA margin 37.2%
Contribution obligation
₹11.36 Lakh
As per LLP agreement
Open charges
₹32.98 Cr
Satisfied ₹1.9 Cr
LLP age
11 yrs
Est. 2015
Employees · EPFO
98
Provident fund records
Designated partners
2
As per MCA filings

About MSP Medicines LLP

Data last updated:

MSP Medicines LLP is a limited liability partnership (LLP) based in Mumbai, Maharashtra, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 19 June 2015 and has been in existence for over 11 years.

The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAE-2082. Its GSTIN is 27AABFZ4538M1ZM (Maharashtra).

The LLP has a total obligation of contribution of ₹11.36 Lakh. It is led by designated partners Sunil Haripant Pophale and Paras Vinod Gandhi.

Its latest statement of accounts is for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2023, the LLP reported a revenue of ₹27.9 Cr. For the same year it recorded a net profit of ₹4.89 Cr (net margin 17.5%) and EBITDA of ₹10.38 Cr (EBITDA margin 37.2%). Revenue has grown at a compounded annual rate (CAGR) of 51% over three years and 83% over five years.

The LLP has about 98 employees on its provident fund (EPFO) records.

The LLP is associated with 1 brand: Zenvision Pharma. As per MCA filings, the LLP has open charges of ₹32.98 Cr and satisfied charges of ₹1.9 Cr on record. Court records list 7 cases involving the LLP, including 1 filed by the LLP and 6 filed against it; 4 cases are pending.

MSP Medicines LLP is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0118947). For more details, the LLP can be reached via its website zenvisionpharma.com.

Company details

LLPIN AAE-2082
Incorporation Date 19 June 2015
Total Obligation of Contribution ₹11.36 Lakh
ROC Mumbai
Company Status Active
MSME Classification Medium
Udyam Registration UDYAM-MH-33-0118947

Recognitions & Rankings of MSP Medicines

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-MH-33-0118947

Contact details

MSP Medicines LLP's registered office is in Mumbai, Maharashtra. Its website is zenvisionpharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    1st Floor Plot No.4 K Chambers Purushottamdas Thakurdas Road Siddharth College Fort M, Umbai, Mumbai, Maharashtra, India – 400001
  • Industry
    Pharma, Pharma Contract R&D

To see the full contact details of MSP Medicines LLP, buy the company report.

Comprehensive company report
MSP Medicines LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

MSP Medicines operates one associated brand: Zenvision Pharma. Each brand links to its own profile.

BrandDescriptionWebsite
Provides pharmaceutical formulation development and contract manufacturing services globally.zenvisionpharma.com

Financials of MSP Medicines LLP

FY 2024 filings available

MSP Medicines LLP reported revenue of ₹27.9 Cr for FY 2023.

Revenue · FY 2023
₹27.9 Cr
Net profit · FY 2023
₹4.89 Cr margin 17.5%
EBITDA · FY 2023
₹10.38 Cr margin 37.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
3 years · compounded
▲ 51%
5 years · compounded
▲ 83%

Revenue has grown at a compounded annual rate (CAGR) of 83% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

Statement of Account and SolvencyFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Income and Expenditure
Turnover
Other Income
Total Income
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax₹4.89 Cr
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
Net Profit Margin17.5%
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of MSP Medicines LLP, buy the company report.

Designated partners of MSP Medicines LLP

MSP Medicines has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Sunil Haripant PophaleDesignated Partner19 Jun 201511 Years 5 MonthsCurrent
Paras Vinod GandhiPartner01 Sep 20206 Years 2 MonthsCurrent

Peer comparison

MSP Medicines LLP is compared with the 10 companies closest to it by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
MSP Medicines LLPthis company₹27.9 Cr (FY 2023)₹4.89 Cr17.5%Mumbai, Maharashtra, India
Zieo Pharmaceuticals Private Limited₹10.38 Cr (FY 2025)37.0%Bangalore, Karnataka, India
Li Med Labs Private Limited₹10.19 Cr (FY 2025)26.0%Thiruvananthapuram, Kerala, India
Olene Life Sciences Private Limited₹10.14 Cr (FY 2025)169.0%Chennai, Tamil Nadu, India
RXMD Pharmaceutical Physicians Private Limited₹10.13 Cr (FY 2025)9.0%Chennai, Tamil Nadu, India
Sipra Labs Limited₹10.01 Cr (FY 2024)-19.0%Hydrabad, Telangana, India
Genei Laboratories Private Limited₹9.99 Cr (FY 2025)-8.0%Bangalore, Karnataka, India
Minal Specialities Private Limited₹9.95 Cr (FY 2025)Ahmedabad, Gujarat, India
KMS Health Center Private Limited₹9.9 Cr (FY 2024)3.0%Chennai, Tamil Nadu, India
Catawba Research (India) Private Limited₹9.86 Cr (FY 2025)-2.0%Mumbai, Maharashtra, India
Vanta Bioscience Limited₹9.83 Cr (FY 2024)41.0%Secunderabad, Telangana, India

To see the full peer comparison of MSP Medicines LLP, buy the company report.

Charges & borrowings

Open charges
₹32.98 Cr
Satisfied charges
₹1.9 Cr
Breakdown by lending institutions
Bank of India₹31.00 Cr
Canara Bank₹1.98 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
03 Nov 2022100641945Bank of India₹31 CrOpen
27 Sep 2021100498043Canara Bank₹1.98 CrOpen
31 May 2022100631449Profectus Capital Private Limited₹1.9 CrSatisfied

To see the full charge records of MSP Medicines LLP, buy the company report.

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for MSP Medicines LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

MSP Medicines has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AABFZ4538M1ZMMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of MSP Medicines LLP, buy the company report.

Recent activity

MSP Medicines LLP has 3 designated partner changes on record since 2015: 2 appointments and 1 cessation. The latest: Bobba Venkata Sivakumar ceased to be Designated Partner on 22 Jan 2026.

Ceased
Bobba Venkata Sivakumar ceased to be Designated Partner.
AGM
Msp Medicines Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Charges
A charge registered on 31 May 2022 via Charge ID 100631449 with Profectus Capital Private Limited was fully satisfied on 03 Sep 2024.
Filing
Msp Medicines Llp has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Bank Of India amounted to Rs. 3,100.00 Lakh with Charge ID 100641945 was registered on 03 Nov 2022.
Charges
A charge with Profectus Capital Private Limited amounted to Rs. 190.00 Lakh with Charge ID 100631449 was registered on 31 May 2022.
Charges
A charge with Canara Bank amounted to Rs. 198.00 Lakh with Charge ID 100498043 was registered on 27 Sep 2021.
Appointed
Paras Vinod Gandhi was appointed as Partner.
Appointed
Sunil Haripant Pophale was appointed as Designated Partner.
Incorporation
19 Jun 2015
Msp Medicines Llp was registered on 19 Jun 2015 with Roc Mumbai & aged 11 years 5 months as per MCA records.

Frequently asked questions

MSP Medicines is an active limited liability partnership based in Mumbai, Maharashtra, India. The LLP works in pharma contract r and d, within the pharma industry. It was incorporated on 19 June 2015 (11+ years old) and is registered under LLPIN AAE-2082.

MSP Medicines has 2 current designated partners:

The latest financial statements of MSP Medicines on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2016 are in the company report.

The GSTIN of MSP Medicines is 27AABFZ4538M1ZM, registered in Maharashtra.

The LLPIN (Limited Liability Partnership Identification Number) of MSP Medicines is AAE-2082. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

MSP Medicines has 7 court cases on record: 1 filed by the LLP and 6 filed against it. 4 are pending. Most are in the district courts.

MSP Medicines was incorporated on 19 June 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of MSP Medicines by revenue are Zieo Pharmaceuticals Private Limited, Li Med Labs Private Limited, Olene Life Sciences Private Limited, RXMD Pharmaceutical Physicians Private Limited, Sipra Labs Limited and 5 more, all in the Pharma industry (Contract Research).

Bobba Venkata Sivakumar ceased to be Designated Partner on 22 Jan 2026. Paras Vinod Gandhi was appointed as Partner on 01 Sep 2020. Sunil Haripant Pophale was appointed as Designated Partner on 19 Jun 2015.

Yes, MSP Medicines is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-33-0118947).

MSP Medicines can be reached through the website zenvisionpharma.com. Its registered office is in Mumbai, Maharashtra, India.